共 28 条
[1]
BARLOZZARI T, 1985, J IMMUNOL, V134, P2783
[2]
Baxevanis CN, 2000, EUR J IMMUNOL, V30, P1957, DOI 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO
[3]
2-7
[5]
Byun MW, 1994, RADIOISOTOPE NEWS, V9, P32
[7]
Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer
[J].
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES,
2004, 1663 (1-2)
:167-177
[9]
Field CJ, 2000, AM J CLIN NUTR, V71, p1720S, DOI 10.1093/ajcn/71.6.1720S